Early Stage HER2 Positive Breast Cancers Not Achieving A pCR From Neoadjuvant Trastuzumab Or Pertuzumab Based Regimens Have An Immunosuppressive Phenotype
Force, Jeremy, Howie, Lynn J., Abbott, Sara E., Bentley, Rex, Marcom, P. Kelly, Kimmick, Gretchen, Westbrook, Kelly, Sammons, Sarah L., Parks, Michelle, Topping, Donna L., Emerson, Ryan, Broadwater, GLanguage:
english
Journal:
Clinical Breast Cancer
DOI:
10.1016/j.clbc.2018.02.010
Date:
February, 2018
File:
PDF, 4.55 MB
english, 2018